Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: interim analysis of the DosEmi study.
- DOI
- 10.1016/j.jtha.2025.10.029
- Published
- 2025-11-07
- Container
- J Thromb Haemost
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtha.2025.10.029,
title = {Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: interim analysis of the DosEmi study.},
author = {van der Zwet K and de Vos ADW and Cnossen MH and Heubel-Moenen FCJI and Schols SEM and Ypma PF and den Exter PL and Hooimeijer HL and Coppens M and Mathôt RAA and Janssen A and Donners AAMT and Kruis I and Urbanus RT and van Vulpen LFD and Eckhardt CL and Schutgens REG and Fischer K and OPTI-CLOT Study Group and SYMPHONY Consortium.},
year = {2026},
journal = {J Thromb Haemost},
doi = {10.1016/j.jtha.2025.10.029},
url = {https://doi.org/10.1016/j.jtha.2025.10.029}
}RIS
TY - JOUR TI - Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: interim analysis of the DosEmi study. AU - van der Zwet K AU - de Vos ADW AU - Cnossen MH AU - Heubel-Moenen FCJI AU - Schols SEM AU - Ypma PF AU - den Exter PL AU - Hooimeijer HL AU - Coppens M AU - Mathôt RAA AU - Janssen A AU - Donners AAMT AU - Kruis I AU - Urbanus RT AU - van Vulpen LFD AU - Eckhardt CL AU - Schutgens REG AU - Fischer K AU - OPTI-CLOT Study Group and SYMPHONY Consortium. PY - 2026 JO - J Thromb Haemost DO - 10.1016/j.jtha.2025.10.029 UR - https://doi.org/10.1016/j.jtha.2025.10.029 ER -
APA
K, V. D. Z., ADW, D. V., MH, C., FCJI, H., SEM, S., PF, Y., PL, D. E., HL, H., M, C., RAA, M., A, J., AAMT, D., I, K., RT, U., LFD, V. V., CL, E., REG, S., K, F., & Consortium., O. S. G. A. S. (2026). Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: interim analysis of the DosEmi study.. J Thromb Haemost. https://doi.org/10.1016/j.jtha.2025.10.029
Source records
- europe-pmc · retrieved 2026-09-27T02:48:46.090Z